Off-site Stability Storage Facility Expands Capacity - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Off-site Stability Storage Facility Expands Capacity



Parameter Stability Storage has expanded by 30% its stability storage space for products that require International Conference on Harmonization (ICH)-specified environmental conditions.

The company’s stability storage rooms and chambers are fully validated to meet strict temperature, humidity, and uniformity controls. Chambers and rooms are monitored 24/7 and are cGMP compliant.

Parameter Stability Storage rooms and chambers have been mapped and validated for FDA-mandated long-and short-term shelf life studies under various temperature and humidity requirements.

In addition, the company offers back-up contingency storage to businesses whose own stability storage facilities prove inadequate because of space constraints, disastrous weather conditions, or electrical failures.

Source: Parameter Stability Storage

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What role should the US government play in the current Ebola outbreak?
Finance development of drugs to treat/prevent disease.
Oversee medical treatment of patients in the US.
Provide treatment for patients globally.
All of the above.
No government involvement in patient treatment or drug development.
Finance development of drugs to treat/prevent disease.
23%
Oversee medical treatment of patients in the US.
14%
Provide treatment for patients globally.
7%
All of the above.
47%
No government involvement in patient treatment or drug development.
9%
Jim Miller Outsourcing Outlook Jim MillerOutside Looking In
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAdvances in Large-Scale Heterocyclic Synthesis
Jill Wechsler Regulatory Watch Jill Wechsler New Era for Generic Drugs
Sean Milmo European Regulatory WatchSean MilmoTackling Drug Shortages
New Congress to Tackle Health Reform, Biomedical Innovation, Tax Policy
Combination Products Challenge Biopharma Manufacturers
Seven Steps to Solving Tabletting and Tooling ProblemsStep 1: Clean
Legislators Urge Added Incentives for Ebola Drug Development
FDA Reorganization to Promote Drug Quality

Click here